Home | Articles
Published on:January 2024
Indian Journal of Pharmaceutical Education and Research, 2024; 58(1s):s9-s25
Review Article | doi:10.5530/ijper.58.1s.2

Role of Social Media for Drug Safety Signal Detection


Authors and affiliation (s):

Kunjbihari Sulakhiya*, Sushim Kanchan, Haroon Ansari, Anglina Kisku

Department of Pharmacy, Neuropharmacology Research Laboratory (NPRL), Indira Gandhi National Tribal University, Amarkantak, Madhya Pradesh, INDIA.

Abstract:

Drug safety is an important factor considered during the drug discovery and development stages to develop safe and efficacious medicines for patients. Post-marketing surveillance is the commonly used method to obtain Adverse Drug Reaction (ADR) data of a marketed product through spontaneous reporting. In recent years, drug side effects are a major concern related to public health, increasing hospitalization and mortality rates. Social media has gained popularity in communicating and sharing every aspect of human life, including health-related information. The advantages of using social media to detect and report pharmacovigilance signals include the dissemination of data among healthcare professionals and stakeholders in a real-time and timely manner. The main objective of this review article is to explore the possible role of social media in the detection of a drug safety signal. It is observed from the extensive review that patients are seeking advice and getting information about health, disease, and medications from different social networks such as LinkedIn, Facebook, WhatsApp, Twitter, Pharmacovigilance Programme of India (PvPI) app, PubMed, MedHelp, PatientsLikeMe, etc It is concluded that social networks can be a useful tool for the detection of a drug safety signal. Thus, few limitations of traditional data sources or signal analysis suggested that these traditional signal analyses can be supplemented with data gathered from social media.

Keywords: Pharmacovigilance, Adverse Drug Reactions, Drug Safety, Signal Detection, Social Media.

 




 

Impact Factor

IJPER - An Official Publication of Association of Pharmaceutical Teachers of India is pleased to announce continued growth in the Latest Release of Journal Citation Reports (source: Web of Science Data).

 

Impact Factor® as reported in the 2023 Journal Citation Reports® (Clarivate Analytics, 2023): 0.8

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmaceutical Education and Research (IJPER) [ISSN-0019-5464] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 1967.

DOI HISTORY

IJPER uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2013 are being assigned DOIs for its permanent URLs